Young normal, elderly, and clinically diagnosed Alzheimer disease subjects who had undergone positron emission tomography (PET) and computed tomography (CT) examinations were studied to determine the effect of periventricular white matter lesions on cerebellar glucose metabolic rates. PET-determined cerebellar metabolic rates were elevated in subjects with periventricular white matter lesions. These results suggest the cautious use of cortical-to-cerebellar ratios in future PET or single-photonemission CT (SPECT) studies.
BrunA.EnglundE. (1986) A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study. Ann Neurol19:253–262
2.
ChaseT.N.FosterN.L.MansiI. (1983) Alzheimer's disease and the parietal lobe. Lancet2:225
3.
De LeonM.J.FerrisS.H.GeorgeA.E.ChristmanD.R.GentesC.ReisbergB.GeeB.EmmerichM.YonekuraY.BrodieJ.KricheffIIWolfA. (1983) Positron emission tomography studies of aging and Alzheimer's disease. Am J Neuroradiol4:568–571
4.
De LeonM.J.GeorgeA.E.MillerJ.D.KlugerA.GianutsosJ.KlingerA.FerrisS.H.La ReginaM.E.WolfA.P. (1987) Longitudinal and PET studies of leukoencephalopathy in normal aging. Presented at the 25th Annual Meeting of the American Society of Neuroradiol, New York, May 10–16
5.
FriedlandR.P.BrunA.BudingerT.F. (1985) Pathological and positron emission tomographic correlations in Alzheimer's disease. Lancet1:228
6.
GeorgeA.E.De LeonM.J.GentesC.I.MillerJ.LondonE.BudzilovichG.N.FerrisS.H.ChaseN. (1986) Leukoencephalopathy in normal and pathologic aging: 1. CT of brain lucencies. Am J Neuroradiol7:561–566
7.
GhezC.FahnS. (1981) The cerebellum. In: Principles of Neural Science (KandelE.R.SchwartzJ.H., eds), New York, Elsevier/North-Holland, pp 334–346
HolmanB.L. (1986) Perfusion and receptor SPECT in the dementias—George Taplin memorial lecture. J Nucl Med27: 855–860
10.
KushnerM.AlaviA.ReivichM.DannR.BurkeA.RobinsonG. (1984) Contralateral cerebellar hypometabolism following cerebral insult: A positron emission tomographic study. Ann Neurol15:425–434
11.
McGeerP.L.KamoH.HarropR.LiD.K.B.TuokkoH.McGeerE.G.AdamM.J.AmmannW.BeattieB.L.CalneD.B.MartinW.R.W.PateB.D.RogersJ.G.RuthT.J.SayreC.I.StoesslA.J. (1986) Positron emission tomography in patients with clinically diagnosed Alzheimer's disease. Can Med Assoc J134:597–607
12.
McKhannG.DrachmanD.FolsteinM.KatzmanR.PriceD.StadlanE.M. (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology34:939–944
13.
MuellerS.P.JohnsonK.A.HamilD.EnglishR.J.NagelS.J.IchiseM.HolmanB.L. (1986) Assessment of I-123 IMP SPECT in mild/moderate and severe Alzheimer's disease. J Nucl Med27:889
ReisbergB.FerrisS.H.De LeonM.J.CrookT. (1982) The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatr139:1136–1139
16.
ReivichM.AlaviA.WolfA.FowlerJ.RussellJ.ArnettC.MacGregorR.R.ShiueC.Y.AtkinsH.AnandA.DannR.GreenbergJ. (1985) Glucose metabolic rate kinetic model parameter determination in humans: The lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose. J Cereb Blood Flow Metab5:179–192
17.
RezekD.L.MorrisJ.C.FullingK.H.GadoM.H. (1987) Periventricular white matter lucencies in senile dementia of the Alzheimer type and in normal aging. Neurology37:1365–1368
